Category
R&D Institution
Scientific area(s)
1.6 Biological sciences (Medical sciences go to scientific area 3.n; Agricultural sciences go to scientific area 4.n)
3.3 Health sciences
2.9 Industrial biotechnology
Brief description
iBET is a private non-profit research intensive institution with over 25 years of experience in developing innovative solutions for the biopharmaceutical industry, SMEs, academic and private institutions.Key areas of expertise include the bioprocessing, production and in depth analysis of recombinant proteins and monoclonal antibodies, viral vaccines, viral vectors for gene therapy and stem cells for cell therapy applications; and in the development of in-vitro advanced cell models for pre-clinical research (eg. cancer, neural).iBET’s infrastructure comprises 16 cutting edge laboratories, a GMP certified Analytical Services Unit, a Pilot Plant for bioprocess development and production scale up and partners with the GMP manufacturer Genibet (45% owned by iBET, www.genibet.com) for production of biopharmaceutical for phase I/II clinical trials.IBET is also the coordinator of the “iNOVA4Health – Advancing Precision Medicine” Research Unit (www.inova4health.com), which organizes the efforts of biomedical researchers involved in biological understanding of disease, lead compounds and biopharmaceuticals “pre-discovery”, technological scientists involved in “preclinical development”, and clinicians involved in “early clinical and first in man clinical trials”.Trusting partners include international pharmaceutical companies, such as Bayer Healthcare, Novartis Pharma, Merck Serono, Abbvie, Sanoffi, Apceth, AstraZeneca, GSK, Merck & Co.
Website
Mailing address
Av. República, Qta. do Marquês. Estação Agronómica Nacional. Edificio IBET/ITQB. 2780-157 Oeiras - Portugal
-
Postal Code
2780-157
-
City
Oeiras
Country
Portugal
Contact person
Isabel Ribeiro
-
Contact person's e-mail
iribeiro@ibet.pt
-
Telephone
+351 21 442 77 87
Last edited on
2018-12-03 10:49:58